"Vancomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
Descriptor ID |
D014640
|
MeSH Number(s) |
D09.400.420.925 D12.644.233.925
|
Concept/Terms |
Vancocin- Vancocin
- Vancocin HCl
- Vancomycin Lilly
- Vancocine
|
Below are MeSH descriptors whose meaning is more general than "Vancomycin".
Below are MeSH descriptors whose meaning is more specific than "Vancomycin".
This graph shows the total number of publications written about "Vancomycin" by people in this website by year, and whether "Vancomycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1999 | 1 | 1 | 2 |
2005 | 0 | 1 | 1 |
2006 | 0 | 2 | 2 |
2008 | 1 | 1 | 2 |
2011 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2014 | 2 | 0 | 2 |
2015 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
2019 | 0 | 1 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vancomycin" by people in Profiles.
-
Skelly JD, Chen F, Chang SY, Ujjwal RR, Ghimire A, Ayers DC, Song J. Modulating On-Demand Release of Vancomycin from Implant Coatings via Chemical Modification of a Micrococcal Nuclease-Sensitive Oligonucleotide Linker. ACS Appl Mater Interfaces. 2023 Aug 09; 15(31):37174-37183.
-
Jahan F, Zaman SU, Syed MA, Arshad R, Amjad O, Ali I, Gul R, Shahnaz G, Aamir MN, Hanif S. HPLC method development and validation for in vitro and in vivo quantification of vancomycin in rabbit plasma. Pak J Pharm Sci. 2022 Nov; 35(6(Special)):1683-1690.
-
Zhang B, Braun BM, Skelly JD, Ayers DC, Song J. Significant Suppression of Staphylococcus aureus Colonization on Intramedullary Ti6Al4V Implants Surface-Grafted with Vancomycin-Bearing Polymer Brushes. ACS Appl Mater Interfaces. 2019 Aug 14; 11(32):28641-28647.
-
Psoinos CM, Collins CE, Ayturk MD, Anderson FA, Santry HP. Post-hospitalization Treatment Regimen and Readmission for C. difficile Colitis in Medicare Beneficiaries. World J Surg. 2018 01; 42(1):246-253.
-
Syed MA, Ashfaq N, Saleem A, Fatima B. Reliability of Vancomycin Sensitivity Assays for Staphylococcus Aureus. J Coll Physicians Surg Pak. 2017 Dec; 27(12):795.
-
Proulx MK, Palace SG, Gandra S, Torres B, Weir S, Stiles T, Ellison RT, Goguen JD. Reversion From Methicillin Susceptibility to Methicillin Resistance in Staphylococcus aureus During Treatment of Bacteremia. J Infect Dis. 2016 Mar 15; 213(6):1041-8.
-
Wargo KA, McCreary EK, English TM. Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections. Clin Infect Dis. 2015 Oct 01; 61(7):1148-54.
-
Skelly JD, Lange J, Filion TM, Li X, Ayers DC, Song J. Vancomycin-bearing synthetic bone graft delivers rhBMP-2 and promotes healing of critical rat femoral segmental defects. Clin Orthop Relat Res. 2014 Dec; 472(12):4015-23.
-
Causey MW, Walker A, Cummings M, Johnson EK, Maykel JA, Steele S. Colonic decompression and direct intraluminal medical therapy for Clostridium difficile-associated megacolon using a tube placed endoscopically in the proximal colon. Colorectal Dis. 2014 Feb; 16(2):O71-4.
-
Li X, Xu J, Filion TM, Ayers DC, Song J. pHEMA-nHA encapsulation and delivery of vancomycin and rhBMP-2 enhances its role as a bone graft substitute. Clin Orthop Relat Res. 2013 Aug; 471(8):2540-7.